Stocks and InvestingStocks and Investing
Fri, June 17, 2016
Thu, June 16, 2016
Wed, June 15, 2016
Tue, June 14, 2016
Mon, June 13, 2016
Fri, June 10, 2016
Thu, June 9, 2016
Wed, June 8, 2016
Tue, June 7, 2016
Mon, June 6, 2016
Sun, June 5, 2016
Fri, June 3, 2016
Thu, June 2, 2016
Wed, June 1, 2016
Tue, May 31, 2016
Fri, May 27, 2016
Thu, May 26, 2016
Wed, May 25, 2016
Tue, May 24, 2016
Mon, May 23, 2016
Fri, May 20, 2016
Thu, May 19, 2016

Keay Nakae Initiated (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016


Published on 2024-10-25 17:03:41 - WOPRAI, Keay Nakae
  Print publication without navigation


Keay Nakae of Chardan Capital, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016.

Keay, nor any peers, have made any analyst calls on ARWR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30